2534
M. L. Bohn et al. / Carbohydrate Research 342 (2007) 2522–2536
tography afforded acetates 19d and 20d allowing their
full characterization.
reaction mixture afforded a mixture of disaccharides
19e and 20e (50%), trisaccharide 21 (28%) and unreacted
acceptor 11c (9.6%). The inseparable mixture of disac-
charides was acetylated, and the acetates 19f and 20f
were isolated and fully characterized.
31
3.2.14.1. Acetate 19d. 27.3%; ½aꢁD +70.9 (c 1.01,
CHCl3); Rf 0.38 (3:7 hexane–EtOAc); 1H NMR
(300 MHz): d 7.40–7.28 (m, 5H, ArH), 5.29 (dd, 1H,
29
J4 ;5 1:0, J4 ;3 3:4 Hz, H-40), 5.15 (dd, 1H, J3,4 8.8, J3,2
10.9 Hz, H-3), 5.01 (dd, 1H, J4,5 10.3 Hz, H-4), 4.94 (dd,
3.2.15.1. Acetate 19f. 49.8%; ½aꢁD +52.1 (c 1.04,
0
0
0
0
CHCl3); Rf 0.34 (1:1 hexane–EtOAc, two develop-
ments); 1H NMR (300 MHz): d 7.75–7.60, 7.50–7.35
1H, J2 ;1 7:8, J2 ;3 10:4 Hz, H-20), 4.85 (dd, 1H, H-30),
4.63 (d, 1H, J1,2 3.8 Hz, H-1), 4.56 (d, 1H, J 12.0 Hz,
CH2Ph), 4.52 (d, 1H, CH2Ph), 4.45 (d, 1H, H-10), 4.24
(dd, 1H, H-2), 4.12–4.06 (m, 2H, H-60a, H-60b), 4.01–3.92
(m, 1H, H-5), 3.87–3.80 (m, 1H, H-50), 3.57–3.52 (m, 2H,
H-6a, H-6b), 3.32 (s, 3H, OCH3), 2.13, 2.06, 1.97, 1.93,
1.80 (5s, 15H, COCH3 · 5), 2.02, 1.98 (2br s, 6H,
CCH3 · 2); 13C NMR (75 MHz): d 170.15–168.61 (CO),
138.63–135.89 (C-Ar, C · 2), 128.17–127.49 (C-Ar),
99.32 (C-10), 98.49 (C-1), 73.37 (CH2Ph), 72.82 (C-3),
70.85 (C-30), 70.32 (C-50), 69.89 (C-4), 69.03 (C-20), 68.76
(C-5, C-6), 66.77 (C-40), 60.73 (C-60), 55.19 (OCH3), 55.00
(C-2), 20.71–20.21 (COCH3 · 5), 8.80, 8.67 (CCH3);
HRFABMS: calcd for C36H45NO17 [M+Na]+, m/z
786.2585; found, m/z 786.2606.
0
0
0
0
0
0
0
0
(m, 10H, ArH), 5.29 (dd, 1H, J4 ;5 0:8, J4 ;3 3:2 Hz, H-
40), 5.13 (dd, 1H, J3,4 9.0, J3,2 11.0 Hz, H-3), 4.93 (dd,
1H, J2 ;1 7:7, J2 ;3 10:6 Hz, H-20), 4.89 (dd, 1H, J4,5
10.0 Hz, H-4), 4.84 (dd, 1H, H-30), 4.63 (d, 1H, J1,2
3.8 Hz, H-1), 4.45 (d, 1H, H-10), 4.21 (dd, 1H, H-2),
4.12–4.02 (m, 2H, H-60a, H-60b), 3.96–3.87 (m, 1H, H-
5), 3.87–3.79 (m, 1H, H-50), 3.74 (dd, 1H, J6a,5 6.2,
J6a,6b 11.1 Hz, H-6a), 3.66 (dd, 1H, J6b,5 2.2 Hz, H-
6b), 3.33 (s, 3H, OCH3), 2.11, 2.06, 1.92, 1.87, 1.79
(5s, 15H, COCH3 · 5), 2.02, 1.98 (2s, 6H, CCH3 · 2),
1.04 (s, 9H, C (CH3)3); 13C NMR (75 MHz): d 172.18–
168.67 (CO), 135.54–133.12 (C · 2, C-Ar), 129.54–
127.55 (C-Ar), 99.38 (C-10), 98.33 (C-1), 73.09 (C-3),
70.91 (C-30), 70.72 (C-5), 70.32 (C-50), 69.73 (C-4),
69.08 (C-20), 66.80 (C-40), 63.19 (C-6), 60.79 (C-60),
55.14 (C-2), 55.07 (OCH3), 26.60 (C(CH3)3), 20.65–
20.26 (COCH3), 19.04 (C(CH3)3), 8.86, 8.72 (CCH3);
HRFABMS: calcd for C45H57NO17Si [M+Na]+, m/z
934.3293; found, m/z 934.3274.
0
0
0
0
30
3.2.14.2. Acetate 20d. 28.9%; ½aꢁD +77.0 (c 1.02,
CHCl3); Rf 0.30 (3:7 hexane–EtOAc); 1H NMR
(300 MHz): d 7.46–7.31 (m, 5H, ArH), 6.21 (dd, 1H,
0
0
J3,4 8.5, J3,2 11.4 Hz, H-3), 5.25 (dd, 1H, J4 ;5 0:9,
J4 ;3 3:5 Hz, H-40), 4.98 (dd, 1H, J2 ;1 7.9, J2 ,3
0
0
0
0
0
0
31
10.3 Hz, H-20), 4.82 (d, 1H, J 12.0 Hz, CH2Ph), 4.76
(dd, 1H, H-30), 4.70 (d, 1H, J1,2 3.8 Hz, H-1), 4.46 (d,
1H, CH2Ph), 4.39 (d, 1H, H-10), 4.34 (dd, 1H, H-2),
3.2.15.2. Acetate 20f. 30.5%; ½aꢁD +69.3 (c 1.01,
CHCl3); Rf 0.25 (1:1 hexane–EtOAc); 1H NMR
(300 MHz): d 7.82–7.68, 7.50–7.35 (m, 10H, ArH),
6.25 (dd, 1H, J3,4 9.5, J3,2 11.4 Hz, H-3), 5.29 (dd, 1H,
4.05 (d, 2H, J6 ;5 6:8 Hz, H-60a, H-60b), 3.98–3.78 (m,
3H, H-4, H-5, H-6a), 3.67 (dd, 1H, J6b,5 1.2, J6b,6a
10.6 Hz, H-6b), 3.59 (ddd with appearance of dt, 1H,
H-50), 3.30 (s, 3H, OCH3), 2.12, 2.07, 1.954, 1.95, 1.91
(5s, 15H, COCH3 · 5), 1.94 (s, 6H, CCH3 · 2); 13C
NMR (75 MHz): d 170.20–168.38 (CO), 137.37, 137.02
(C-Ar, C · 2), 128.57–128.09 (C-Ar), 99.82 (C-10),
98.58 (C-1), 75.57 (C-4), 73.59 (CH2Ph), 70.96 (C-30),
70.34 (C-50), 69.70 (C-5), 69.12 (C-20), 67.12 (C-3, C-
6), 66.77 (C-40), 60.87 (C-60), 55.20 (OCH3), 53.39 (C-
2), 20.84–20.38 (COCH3 · 5), 8.67 (CCH3 · 2);
HRFABMS: calcd for C36H45NO17 [M+Na]+, m/z
786.2585; found, m/z 786.2613.
0
0
J4 ;5 0:9, J4 ;3 3:1 Hz, H-40), 5.07 (dd, 1H, J2 ;1 8.0,
0
0
0
0
0
0
J2 ;3 10:2 Hz, H-20), 4.87 (dd, 1H, H-30), 4.81 (d, 1H,
H-10), 4.71 (d, 1H, J1,2 3.7 Hz, H-1), 4.34 (dd, 1H, H-
2), 4.16–4.05 (m, 3H, H-4, H-60a, H-60b), 3.98 (dd,
1H, J6a,5 2.3, J6a,6b 11.8 Hz, H-6a), 3.90 (dd, 1H, J6b,5
1.1 Hz, H-6b), 3.80–3.67 (m, 2H, H-50, H-5), 3.24 (s,
3H, OCH3), 2.14, 2.06, 1.98, 1.96, 1.82 (5s, 15H,
COCH3 · 5), 1.96 (s, 6H, CCH3 · 2), 1.11 (s, 9H, C
(CH3)3); 13C NMR (75 MHz): d 170.23–168.50 (CO),
137.08–135.31 (C · 2, C-Ar), 133.37–127.56 (C-Ar),
99.85 (C-10), 98.46 (C-1), 75.32 (C-4), 71.14 (C-30),
70.62 (C-5*), 70.54 (C-50*), 69.32 (C-20), 67.24 (C-3),
66.90 (C-40), 61.15 (C-6*), 61.04 (C-60*), 54.98 (OCH3),
53.64 (C-2), 26.76 (C (CH3)3), 20.95–20.42 (COCH3),
19.35 (C(CH3)3), 8.76 (CCH3 · 2); HRFABMS: calcd
for C45H57NO17Si [M+Na]+, m/z 934.3293; found, m/z
934.3310.
0
0
3.2.15. Methyl 2,3,4,6-tetra-O-acetyl-b-D-galactopy-
ranosyl-(1!3)-4-O-acetyl-6-O-tert-butyldiphenylsilyl-2-
deoxy-2-dimethylmaleimido-a-D-glucopyranoside (19f),
methyl
2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl-
(1!4)-3-O-acetyl-6-O-tert-butyldiphenylsilyl-2-deoxy-2-di-
methylmaleimido-a-D-glucopyranoside (20f) and methyl
2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl-(1!3)-[2,3,4,6-
tetra-O-acetyl-b-D-galactopyranosyl-(1!4)]-6-O-tert-butyl-
diphenylsilyl-2-deoxy-2-dimethylmaleimido-a-D-glucopy-
ranoside (21). Column chromatography of the crude
28
3.2.15.3. Trisaccharide 21. 28%; ½aꢁD +39.3 (c 1.04,
CHCl3); Rf 0.19 (1:1 hexane–EtOAc); 1H NMR
(300 MHz): d 7.80–7.70, 7.50–7.25 (m, 10H, ArH),
5.34 (d, 1H, J3 ;4 3:1 Hz, H-400), 5.30 (d, 1H,
00 00
J3 ;4 3:2 Hz, H-40), 5.16 (dd, 1H, J3,2 9.3, J3,4 10.6 Hz,
0
0